A PHARMACEUTICAL COMPOSITION CONTAINING AN ACTIVE AGENT HAVING THE EFFECT OF DIGITALIS AND A CGMP PHOSPHODIESTERASE INHIBITOR
The invention refers to a cardiotonic pharmaceutical composition having enhanced therapeutical width. The pharmaceutical composition of the invention comprises (a) an active ingredient having the effect of digitalis and (b) a cGMP phosphodiesterase inhibitor and one or more conventional carrier(s)....
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The invention refers to a cardiotonic pharmaceutical composition having enhanced therapeutical width. The pharmaceutical composition of the invention comprises (a) an active ingredient having the effect of digitalis and (b) a cGMP phosphodiesterase inhibitor and one or more conventional carrier(s).
L'invention concerne une composition pharmaceutique cardiotonique possédant une étendue thérapeutique améliorée. Cette composition comprend a) un principe actif à effet digitalique et b) un inhibiteur de phosphodiestérase cGMP, ainsi qu'un ou plusieurs supports classiques. |
|---|